Eurand v. Anchen Pharmaceuticals
Eurand v. Anchen Pharmaceuticals
Opinion
NOTE: This order is nonprecedential.
Wniteb ~tate~ <!Court of §ppeaI~ for !be jfeberaI <!Circuit IN RE CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE PATENT LITIGATION EURAND, INC., CEPHALON, INC., AND ANESTA AG, Plaintiffs·Appellants, v. ANCHEN PHARMACEUTICALS, INC•. AND ANCHEN, INC. Defendants-Appellees.
2011-1408, -1410, -1411, -1412
Appeals from the United States District Court for the District of Delaware in case no. 09-MD-2118, Judge Sue L. Robinson.
ON MOTION
ORDER The appellants move for a 30-day extension of time, until August 31, 2011, to file their opening brief.
EURAND v. ANCHEN PHARMA 2 The court notes that a motion to dismiss these ap- peals was filed on July 25, 2011. Pursuant to Federal Circuit Rule 31(c), the briefing schedule is stayed.
Upon consideration thereof, IT Is ORDERED THAT: The motion is moot.
FOR THE COURT
JUL 262011 lsI Jan Horbaly Date Jan Horbaly Clerk cc: William J. Marsden, Jr., Esq.
Donald J. Mizerk, Esq. s21 FILED U.s. COURT OF APPEALS FOR THE FEDERAL CIRCUIT JUL 25 2011 JAN IWR8AI.Y CLERK
Case-law data current through December 31, 2025. Source: CourtListener bulk data.